Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
nicotine polacrilex, Quantity: 10 mg
Johnson & Johnson Pacific Pty Ltd
Nicotine polacrilex
Gum, chewing
Excipient Ingredients: sodium carbonate; pregelatinised maize starch; xylitol; titanium dioxide; sodium bicarbonate; Peppermint Oil; menthol; acesulfame potassium; light magnesium oxide; sucralose; Carnauba Wax; polysorbate 80; hypromellose; Flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides
Buccal
385, 150, 370, 315, 285, 200, 355, 180, 400, 325, 75, 310, 210, 15, 105, 300, 30, 340, 240, 255, 225, 270
Not scheduled. Not considered by committee
For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. In smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.
Visual Identification: A square, coated, white coloured piece of gum with a minty odour; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2009-10-07